The Los Angeles Post
U.S. World Business Lifestyle
Today: March 18, 2025
Today: March 18, 2025

Bayer must pay $78 million in latest Roundup cancer trial, jury finds

Logo of German drugmaker Bayer AG in Leverkusen
October 10, 2024
Brendan Pierson - Reuters

By Brendan Pierson

(Reuters) -Bayer must pay $78 million to a Pennsylvania man who said he got cancer from using the company's Roundup weedkiller, a state court jury in Philadelphia found on Thursday.

The verdict follows previous consecutive victories for Bayer in that court. The company had won 14 of the previous 20 trials over Roundup, though it has been hit with several massive verdicts in the litigation, including last November for $1.56 billion, later reduced to $611 million, and one in January for $2.25 billion, later reduced to $400 million.

Bayer must pay $78 million in latest Roundup cancer trial, jury finds
FILE PHOTO: Roundup shown for sale in California

Tom Kline and Jason Itkin, lawyers for plaintiff William Melissen and his wife, Margaret, said in a statement that Bayer had "acted with reckless indifference to people's safety."

The company "still has not gotten the message that it needs to change its ways," they said.

The jury awarded $3 million in compensatory damages and $75 million in punitive damages.

"We disagree with the jury's verdict, as it conflicts with the overwhelming weight of scientific evidence and the consensus of regulatory bodies and their scientific assessments worldwide," Bayer said in a statement.

The company said it believed it had a strong argument for reducing the punitive damages on appeal. The U.S. Supreme Court has ruled that punitive damages should generally be no more than nine times compensatory damages.

The Melissens sued Bayer in 2021. They alleged that William, like other Roundup plaintiffs, developed a form of non-Hodgkins lymphoma from exposure to glyphosate, which was the active ingredient in Roundup sold for home use until last year.

Melissen said he used the product at home and at work from 1992 until 2020, when he was diagnosed. He alleges that both glyphosate and another chemical in Roundup caused his cancer.

Bayer maintains that glyphosate does not cause cancer and that the lawsuits are meritless. It acquired Roundup as part of its $63 billion purchase of agrochemical company Monsanto in 2018.

The German company settled most of the then-pending Roundup litigation in 2020 for $10.9 billion, but currently faces about 58,000 claims, according to its most recent financial report.

Bayer won a significant legal victory in August, when the 3rd U.S. Circuit Court of Appeals in Philadelphia ruled that federal law shields Bayer from state law claims, which conflicts with previous rulings by other federal appeals courts.

Bayer has said it will seek to have the U.S. Supreme Court resolve that conflict, and that a victory there could effectively end the Roundup litigation.

Bayer had asked the Philadelphia state court to follow the 3rd Circuit and throw out the case. The 3rd Circuit's jurisdiction includes federal courts in Pennsylvania, but state courts are not legally bound to follow it. That bid was denied, allowing the Melissens' case to go to trial, but the company is appealing the denial.

(Reporting By Brendan Pierson in New York, Editing by Alexia Garamfalvi and Bill Berkrot)

Related Articles

Bayer's Monsanto to pay $160 million to resolve Seattle's PCB contamination lawsuit Australian judge dismisses lawsuit claiming Bayer weedkiller causes blood cancer Bayer eyes wider Nubeqa use on new prostate cancer trial data Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia
Share This

Popular

Asia|Business|Economy|Finance|Stock Markets

Stock market today: Back down goes Wall Street as Big Tech resumes its slide

Stock market today: Back down goes Wall Street as Big Tech resumes its slide
Business|Political|Technology|US

Judge rules DOGE's USAID dismantling likely violates the Constitution

Judge rules DOGE's USAID dismantling likely violates the Constitution
Business|Political|Travel|US

USDOJ in talks with Southwest Airlines to resolve delayed flights lawsuit

USDOJ in talks with Southwest Airlines to resolve delayed flights lawsuit
Americas|Business|Economy

Chile's economy slows in Q4 but full-year growth beats estimates

Chile's economy slows in Q4 but full-year growth beats estimates

Health

Americas|Economy|Health|Political|World

Millions of people and hundreds of staff impacted by US aid cuts, UN migration agency says

Millions of people and hundreds of staff impacted by US aid cuts, UN migration agency says
Health|Political|US

US HHS drops advisory labeling gun violence a public health crisis

US HHS drops advisory labeling gun violence a public health crisis
Business|Health|Technology|US

FDA classifies recall of Medtronic embolization devices as 'most serious'

FDA classifies recall of Medtronic embolization devices as 'most serious'
Americas|Health|US

Measles cases in Texas, New Mexico rise to 317 as outbreak spreads

Measles cases in Texas, New Mexico rise to 317 as outbreak spreads

Access this article for free.

Already have an account? Sign In